There have been some reports indicating that autoimmune disorders such as insulin-dependent diabetes mellitus and celiac disease can develop during treatment with IFN-α for viral hepatitis because of its immune modulatory properties [19][20]. Here, IFNA1 is linked to animal viral hepatitis.